Blueprint Medicines Corp buy Saftman
Start price
30.11.23
/
50%
€64.00
Target price
30.11.24
-
Performance (%)
10.94%
End price
31.01.24
€71.00
Summary
This prediction ended on 31.01.24 with a price of €71.00. The prediction had a final performance of 10.94%. Saftman has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Blueprint Medicines Corp | - | - | - |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % |
Comments by Saftman for this prediction
In the thread Blueprint Medicines Corp diskutieren
Saftman hat das Wertpapier Blueprint Medicines Corp in seinem Wikifolio Langfristige Aufwärtstrends gekauft.